Regenative Labs, With Advanced Medicine of the Ozarks, Publishes Case Study Demonstrating Utilization of Wharton's Jelly Allografts in Supplementing Connective Tissue Defects Associated With Tarsal Tunnel Syndrome
Regenative LabsRegenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating the utilization of its Wharton's Jelly allografts in supplementing connective tissue defects associated with tarsal tunnel syndrome.